ENDEAVOR SPRINT RX CORONARY STENT SYSTEM
Report
- Report Number
- 2953200-2011-00068
- Event Type
- Death
- Date Received
- January 12, 2011
- Date of Event
- January 1, 2009
- Report Date
- December 13, 2010
- Manufacturer
- MEDTRONIC CARDIOVASCULAR GALWAY
- Product Code
- NIQ
- PMA / PMN Number
- P060033
- Removal / Correction Number
- NA
- Adverse Event
- Yes
- Report Source
- Manufacturer report
- Reporter Location
- GM
- Reporter Occupation
- PHYSICIAN
Narratives
(B)(4). EVAL, RESULTS: (DEATH).
THE PT HAD ONE ENDEAVOR SPRINT RAPID EXCHANGE DRUG-ELUTING STENT IMPLANTED TO THE PROXIMAL LAD. PT WAS DISCHARGED TWO WEEKS POST INDEX PROCEDURE ON ASPIRIN AND CLOPIDOGREL. PT CARDIAC STATUS AT 30 DAY F/U WAS STABLE ANGINA. (REF. MFR 2953200-2011-00069). APPROX 6.5 WEEKS POST INDEX POST INDEX PROCEDURE REVASCULARIZATION (PTCA) OF THE PROXIMAL LCX WITH STENTING WAS PERFORMED. INDICATION FOR SURGERY WAS POSITIVE HISTORY OR RECURRENT ANGINA PECTORIS PRESUMABLY RELATED TO THE TARGET VESSEL. THE EVENT WAS CONSIDERED NOT LIFE THREATENING. ONE ENDEAVOR SPRINT RAPID EXCHANGE DRUG-ELUTING STENT WAS IMPLANTED TO THE PROXIMAL LCX. THIS WAS CLASSIFIED AS A NON-TARGET VESSEL. THE INVESTIGATOR INDICATED THAT THE REPORTED EVENT WAS NOT RELATED TO THE STUDY STENT/ PROCEDURE. APPROX 10.5 MONTHS POST INDEX PROCEDURE THE PT SUFFERED A NON SUDDEN CARDIAC DEATH. PT WAS HOSPITALIZED WITH DYSPNOEA AND WEAK CONDITION. INCREASING PLEURAL EFFUSION. WORSENING OF CONDITION REANIMATION AND EXITUS LETALIS. NO AUTOPSY REPORT AVAILABLE. THE INVESTIGATOR INDICATED THAT THE REPORTED EVENT WAS NOT RELATED TO THE STUDY STENT/ PROCEDURE. PT WAS TAKING ASPIRIN AND CLOPIDOGREL/TICLOPIDINE PRIOR TO THE REPORTED EVENT.
Devices
| Seq | Brand | Generic | Product Code | Manufacturer | Model | Lot | UDI-DI |
|---|---|---|---|---|---|---|---|
| 1 | ENDEAVOR SPRINT RX CORONARY STENT SYSTEM | NIQ | MEDTRONIC CARDIOVASCULAR GALWAY | NA | 0000535564 |
Patients
| Seq | Age | Sex | Outcome | Treatment |
|---|---|---|---|---|
| 1 | 82 YR | Death | 24 HOURS BEFORE THE EVENT| CLOPIDOGREL/ TICLOPIDINE| ASPIRIN |